BRIEF-Acrux Says Us FDA Accepted For Review Co's Abbreviated New Drug Application
BRIEF-Acrux Says Us FDA Accepted For Review Co's Abbreviated New Drug Application
Brief-Acrux表示，美国FDA接受了审查公司的简化新药申请
Sept 13 (Reuters) - Acrux Ltd ACR.AX :
路透9月13日电-Acrux Ltd ACR.AX：
* US FOOD AND DRUG ADMINISTRATION HAS ACCEPTED FOR REVIEW CO'S ABBREVIATED NEW DRUG APPLICATION FOR ITS GENERIC VERSION OF DAPSONE GEL, 5%
*美国食品和药物管理局(FDA)已接受CO对其仿制版本氨苯砜凝胶的简短新药申请进行审查，5%
Source text for Eikon: ID:nASXvtvrV Further company coverage: ACR.AX
Eikon的源文本：ID：nASXvtwrV进一步的公司报道：ACR.AX
((Reuters.Briefs@thomsonreuters.com;))
(Reurs.Briefs@thomsonreurs.com；)